Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
A copy of your prescription: A printed copy can be useful if the original packaging labels become damaged or illegible
The outer thigh is fully viable and often preferred by users who find the tirzepatide formulation causes minor skin sensitivity on the abdomen
It binds to melanocortin receptors MC1R through MC5R and has been studied for melanogenesis and photoprotection research
There are no surprise fees, no flat per-compound pricing, and no membership requirements
Most patients enjoy results that last for years
